← FDA Drug Approvals (Drugs@FDA)
RIBOCICLIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC PHARMS LTD · Approved 2024-01-10
Drug application
- FDA Application #
ANDA215677- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIBOCICLIB
- Generic name
- Ribociclib
- Active ingredients
- RIBOCICLIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- ALEMBIC PHARMS LTD
- First approval
- 2024-01-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown